Immunology & Cell Biology
Publishing Critical Research since 1924
2024 Impact Factor 3.0
2024 Scopus Citescore 6.1
ICB spans the breadth of immunology with an emphasis on the cell biology of the immune system. Of particular interest are the areas of cellular immunology, innate and adaptive immunity, immune responses to pathogens, tumour immunology, immunopathology and immunogenetics.
ICB is the home to 90 publications by Burnet in developing his theories leading to the award of the Nobel Prize in Physiology in 1960.
IMMUNOLOGY & CELL BIOLOGY COVERS:
- Cellular immunology
- Immune responses to pathogens
- Immunopathology
- Immunogenetics
- Innate and adaptive immunity
- Tumour immunology
- Immunotherapy
- Immunological studies in humans and model organs (including mouse, rat, Drosophila, etc.)
FEATURES OF IMMUNOLOGY & CELL BIOLOGY
- Quality peer review and a 100-year reputation for excellence
- Rapid evaluation for publication
- Average time to first decision of 2 days and average time to acceptance 7 days
- No publishing fee for subscription articles or for Open Access articles covered under a Transformative Agreement
- Option for Expedited Review if your manuscript has recently undergone peer review at an approved journal with average time to acceptance 7 days
- 2023 Impact Factor 3.2
- 2023 Scopus CiteScore 7.5
- Outstanding Observations – Rapid publication of cutting-edge research
- Original Articles, Reviews, Perspectives, News & Commentaries
- Special Features
- Virtual Issues
- Member of COPE for responsible publication ethics
- Eligibility for the Immunology and Cell Biology Social Impact Award
ADDITIONAL BENEFITS FOR ASI MEMBERS
-
Most members covered under the CAUL Transformative Agreement for Open Access publication
-
For remaining members, receive a 20% discount off the Article Publication Charge for Open Access*
Be in the running for the award of ‘ICB Publication of the Year’, which also includes a speakers slot at the ASI annual meeting**
*Eligible only to current financial ASI members. To receive the member-only code, please contact us. Further information about the Wiley-CAUL agreement can be found here https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/affiliation-policies-payments/institutional-funder-payments.html
**Awarded to the best publication from a current financial ASI member who is first author.
ICB has an Expedited Review process
Immunology & Cell Biology is committed to making a positive culture change in scientific publishing.
'ICB Expedited Review' is an exciting new initiative. ICB is trialling a new, fast-tracked review process of articles with validated reviews at other reputable journals.
Key Features of 'ICB Expedited Review'
ICB will use external peer reviews to make the first decision.
Authors can transfer reviews from another journal to ICB, together with a point-by-point response.
Click here to learn more.
ICB CLASSIC PAPERS
The growth of mouse bone marrow cells in vitro. Bradley, T.R. & Metcalf, D. Aust J Exp Biol Med Sci 44, 287-299 (1966). >2000 citations – a cornerstone publication allowing identification and characterisation of CSFs. |
|
A reassessment of the forbidden clone hypothesis of autoimmune disease. |
ICB Website ICB Access (members login)
Submit a manuscript Download the ICB flyer